Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.
about
Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucomaSoluble guanylate cyclase α1-deficient mice: a novel murine model for primary open angle glaucomaCritical evaluation of latanoprostene bunod in the treatment of glaucomaExciting directions in glaucomaTargeting Schlemm's Canal in the Medical Therapy of Glaucoma: Current and Future Considerations.A class of 4-sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects.Pharmacotherapy of glaucoma.Aqueous humor outflow: dynamics and disease.A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER studyeNOS, a pressure-dependent regulator of intraocular pressure.Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects.Topical treatment of glaucoma: established and emerging pharmacology.Advances in glaucoma treatment and management: outflow drugs.Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study.Biomechanics of Schlemm's canal endothelium and intraocular pressure reduction.Latanoprostene bunod ophthalmic solution 0.024% for IOP lowering in glaucoma and ocular hypertension.The Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies.Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma.The Ability of Nitric Oxide to Lower Intraocular Pressure Is Dependent on Guanylyl Cyclase.Regulation of Aqueous Humor Dynamics by Hydrogen Sulfide: Potential Role in Glaucoma Pharmacotherapy.Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension.
P2860
Q26861763-B91E02EC-38CC-466A-AD9C-84890D40EA1AQ27331498-51B4E405-D89F-4EB4-98E8-CD9EFDBF844CQ28077208-45AC0C5A-56C3-4C31-803D-03267986B88CQ28542397-A70368B9-23FF-4A27-A9B2-B14D2EE5773AQ33665753-4507DC90-178B-4039-B39C-7E58917C348DQ34631556-DFC519A6-854D-418F-8BB7-27AC262EC107Q35138049-35E51D41-40C1-428D-9281-796659E79BCAQ35608780-DE0C8B69-2681-49B7-A4D1-ADF960E695B5Q35677641-E885A269-730C-4D75-B6E4-CDA7B7EF637CQ35801497-4861C693-BFB1-43FA-85D5-4BCACC494E70Q36327163-B37D7D76-54D0-4722-A60B-2370DFF84E80Q36365495-D40ACFA5-645B-40C3-9998-130355F9DE45Q36983331-2E95BC3F-EEDC-4529-82C5-C0EFE5FE1A7DQ37250462-9A03536E-5E31-43D9-A240-B9510E13C4F5Q38249883-44197367-6D86-46FA-8F96-7315A2D4229BQ38405486-376AAFA4-291E-4C9F-84F2-5D069B70FED5Q38637048-B2BB9907-6DE5-4A2A-90A8-7A7DA41374C6Q39207696-BC2E1A53-CCD5-4EB2-A791-2026BB748BB4Q42286473-910CA06A-A2CE-474E-9DE4-0E7D242A2F21Q46245972-BEC59E5A-A40F-4251-B17E-6CEC313FB5C8Q55022142-E81D7C15-B019-41C7-BBF0-349B32504EC6
P2860
Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Ocular hypotensive activity of ...... gonist, in preclinical models.
@ast
Ocular hypotensive activity of ...... gonist, in preclinical models.
@en
type
label
Ocular hypotensive activity of ...... gonist, in preclinical models.
@ast
Ocular hypotensive activity of ...... gonist, in preclinical models.
@en
prefLabel
Ocular hypotensive activity of ...... gonist, in preclinical models.
@ast
Ocular hypotensive activity of ...... gonist, in preclinical models.
@en
P2093
P1476
Ocular hypotensive activity of ...... gonist, in preclinical models.
@en
P2093
Achim H P Krauss
Carol B Toris
David C Gale
Ennio Ongini
Francesco Impagnatiello
Ganesh Prasanna
Samantha T Carreiro
Valentina Borghi
Valerio Chiroli
Wesley K M Chong
P304
P356
10.1016/J.EXER.2011.03.001
P577
2011-03-09T00:00:00Z